Compare PRVA & NVST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRVA | NVST |
|---|---|---|
| Founded | 2007 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 3.6B |
| IPO Year | 2021 | 2019 |
| Metric | PRVA | NVST |
|---|---|---|
| Price | $23.72 | $21.75 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 13 |
| Target Price | ★ $30.46 | $21.17 |
| AVG Volume (30 Days) | 672.5K | ★ 2.4M |
| Earning Date | 11-06-2025 | 02-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 29.88 | N/A |
| EPS | ★ 0.14 | 0.09 |
| Revenue | $2,042,569,000.00 | ★ $2,621,800,000.00 |
| Revenue This Year | $104.97 | $7.42 |
| Revenue Next Year | $9.92 | $3.60 |
| P/E Ratio | ★ $170.33 | $254.73 |
| Revenue Growth | ★ 19.01 | 4.73 |
| 52 Week Low | $18.77 | $14.22 |
| 52 Week High | $26.51 | $22.68 |
| Indicator | PRVA | NVST |
|---|---|---|
| Relative Strength Index (RSI) | 46.63 | 55.57 |
| Support Level | $23.68 | $21.72 |
| Resistance Level | $24.25 | $22.14 |
| Average True Range (ATR) | 0.65 | 0.43 |
| MACD | -0.02 | -0.06 |
| Stochastic Oscillator | 33.92 | 18.86 |
Privia Health Group Inc is a technology-driven, national physician-enablement company. It collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experiences, and reward doctors for delivering high-value care in both in-person and virtual care settings.
Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments; Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment, which derives key revenue, develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. Geographically, the company generates a majority of its revenue from North America, followed by Western Europe and other developed and emerging markets.